Specifically, the results suggest that patients with IBS have an excess of bacteria in the small bowel, known as bacterial overgrowth. As a result, antibiotic-based treatment may be beneficial for IBS. Rifaximin is a non-absorbable antibiotic with no clinically significant bacterial resistance. Rifaximin for IBS is a medicine for treating irritable bowel syndrome with diarrhea. It focuses on the gut microbiome, a collection of bacteria in the digestive tract. Regular bouts of diarrhea, stomach pain, and bloating define IBS-D. Rifaximin helps to relieve these symptoms by inhibiting the growth of bacteria in the small intestine, which can contribute to IBS-D. It is especially beneficial in IBS-D patients with a positive lactulose breath test, indicating small intestine bacterial overgrowth. Rifaximin is taken orally for two weeks and has been demonstrated to provide significant relief from IBS-D symptoms for up to ten weeks after the treatment is stopped.
Here you can have: Generic Cures
